5-HT3 Receptor Antagonist MDL 72222 Dose-Dependently Attenuates Cocaine- and Amphetamine-Induced Elevations of Extracellular Dopamine in the Nucleus Accumbens and the Dorsal Striatum

Pharmacology and Toxicology

Volumn 78, Issue 5, 1996, Pages 317-321

  Kankaanpää, Aino ^a   Lillsunde, Pirjo ^a   Ruotsalainen, Minna ^b   Ahtee, Liisa ^b   Seppälä, Timo ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Div of Pharmacology and Toxicology   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMPHETAMINE; BEMESETRON; COCAINE; DOPAMINE; HOMOVANILLIC ACID; SEROTONIN 3 ANTAGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; TROPANE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINE RELEASE; DRUG ANTAGONISM; DRUG MECHANISM; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; BIOSYNTHESIS; DOSE RESPONSE; DRUG EFFECT; METABOLISM; WISTAR RAT;

AMPHETAMINE; ANIMALS; COCAINE; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; TROPANES;

EID: 0029658955     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1996.tb01382.x     Document Type: Article

References (27)

1. Blaschko, H.: Amine oxidase and amine; metabolism. Pharmacol. Rev. 1952, 4, 415-458.
2. 3 antagonist on drug-induced stimulation of dopamine release. Eur. J. Pharmacol. 1989a, 164, 515-519.
3. 3 receptor antagonists block morphine- and nicotine but not amphetamine-induced reward. Psychopharmacology 1989b, 97, 175-178.
4. Carboni, E., A. Imperato, L. Perezzani & G. Di Chiara: Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 1989c, 28, 653-661.
5. 3 antagonist. GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Brit. J. Pharmacol. 1987, 92, 881-894.
6. Fibiger, H. C. & A. G. Phillips: Dopamine and the neural mechanisms of reinforcement. In: The neurobiology of dopamine. Eds.: A. S. Horn, J. Korf and B. H. C. Westerink. Academic Press, New York, 1979, 597-615.
7. Fozard, J. R.: MDL 72222: a potennnt and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 1984, 326, 36-44.
8. Fuller, R. W.: Selective inhibition of monoamine oxidase. Adv. Biochem. Psychopharmacol. 1972, 5, 339-354.
9. Garattini, S. & R. Samanin: The pharmacological profile of some psychomotor stimulant drugs including chemical, neurophysiological, biochemical and toxicological aspects. In: Handbook of experimental pharmacology. Vol. 55, Part II. Anxiolytics, Gerantopsychopharmacological Agents and Psychomotor Stimulants. Eds.: F. Hoffmeister and G. Stille, Springer-Verlag Heidelberg, 1981, 545-586.
10. 3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse. Psychopharmacology 1993, 112, s69-s75.
11. 3H] dopamine in rat brain tissue slices. Biochem. Pharmacol. 1975, 24, 847-852.
12. 3 receptors control dopamine release in the nucleus accumbens of freely moving rats. Neurosci. Lett. 1989, 101, 214-217.
13. Koe, B. K.: Molecular geometry of inhibitors of the uptake of catecholamines and serotonion in synaptosomal preparations of rat brain. J. Pharmacol. Exp. Therap. 1976, 199, 649-661.
14. Kuczenski, R., D. S. Segal & M. L. Aizenstein: Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotype response profiles and caudate and accumbens dopamine dynamics. J. Neurosci. 1991, 11, 2703-2712.
15. Lane, J. D., C. L. Pickering, M. L. Hooper, K. Fagan, M. B. Tyers & M. W. Emmett-Oglesby: Failure of ondansetron to block the discriminative or reinforcing stimulus effects of cocaine in the rat. Drug Alcohol Depend. 1992, 30, 151-162.
16. 3 receptor antagonist, MDL 72222, on morphine and cocaine stimulated elevation of extracellular dopamine. Regulatory Peptides 1994, Suppl. 1., s223-s224.
17. 3 antagonist zacopride attenuates cocaine-induced increases in extracellular dopamine in rat nucleus accumbens. Pharmacol. Biochem. Behav. 1993, 45, 759-763.
18. 3 antagonists do not alter the discriminative stimulus properties of cocaine. Psychopharmacology 1991, 104, 475-478.
19. Paxinos, G. & C. Watson: The rat brain in stereotaxic coordinates. Academic Press, San Diego 1986.
20. 3 antagonist, fails to alter cocaine self-administration in rats. Pharmacol Biochem. Behav. 1991, 39, 133-136.
21. 3 antagoanist attenuate cocaine-induced locomotion in mice. Eur. J. Pharmacol 1990, 186, 327-330.
22. 3 antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism. Pharmacol. Biochem. Behav. 1992, 43, 871.
23. 3 antagonists block cocaine- and methamphetamine-induced place-preference. Jap. J. Psychopharmacol. 1992, 12, 33-38.
24. 3 receptors suggest new treatment for psychosis and drug addiction. TiPS 1989, 10, 127-129.
25. 3 antagonist, reduces cocaine's psychomotor stimulant effect. Psychopharmacology 1990, 101, s59.
26. Westerink, B. H. C., G. Damsma, J. B. de Vries & H. Koning: Dopamine reuptake inhibitors show inconsistent effects on the in vivo release of dopamine as measured by intracerebral dialysis in the rat. Eur. J. Pharmacol. 1987, 135, 123-128.
27. Wise, R. A. & M. A. Bozarth: Action of drugs of abuse on brain reward systems: An update with specific attention to opiates. Pharmacol. Biochem. Behav. 1982, 17, 239-243.